Search results
HC Wainwright Reiterates Buy Rating for ALX Oncology (NASDAQ:ALXO)
ETF DAILY NEWS· 5 hours agoALX Oncology (NASDAQ:ALXO – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a research note issued on Monday, Benzinga reports. HC Wainwright’s ...
Myka Stauffer Wore $6K Cartier Bracelet in Vlog About Cutting Adopted Son Huxley's Speech Therapy...
People via Yahoo News· 4 days agoAs she discussed her plans, she wore an 18-karat gold Cartier ...
What's the Difference Between Ozempic and Metformin, and Which One Is Right for You?
Parade via Yahoo News· 6 days agoCost Price is a significant differentiating factor between the two. "Metformin is generally...
ProKidney (NASDAQ:PROK) Given New $6.00 Price Target at Jefferies Financial Group
ETF DAILY NEWS· 1 day agoProKidney (NASDAQ:PROK – Free Report) had its target price reduced by Jefferies Financial Group from $15.00 to $6.00 in a research note released on Monday ...
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Consensus Rating of “Buy” from Analysts
ETF DAILY NEWS· 3 days agoShares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) have earned a consensus recommendation of “Buy” from the nine ratings firms that are presently covering the firm, MarketBeat ...
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Rating of “Moderate Buy” by Analysts
ETF DAILY NEWS· 5 hours agoNeedham & Company LLC restated a “buy” rating and set a $53.00 price objective on shares of Rocket Pharmaceuticals in a research note on Tuesday, May 7th ...
StockNews.com Begins Coverage on Cytosorbents (NASDAQ:CTSO)
ETF DAILY NEWS· 1 day agoThe brokerage set a “hold” rating on the medical research company’s stock. B. Riley reaffirmed a “buy” rating and issued a $3.00 price objective on shares of Cytosorbents ...
Jazz Pharmaceuticals' chief accounting officer sells shares worth over $17k By Investing.com
Investing.com· 6 hours agoThe sale has slightly reduced Carr's holdings in the company, but she still retains 6,596 ordinary...
TransMedics Group (NASDAQ:TMDX) Hits New 52-Week High After Analyst Upgrade
ETF DAILY NEWS· 5 hours agoTransMedics Group traded as high as $145.92 and last traded at $144.46, with a volume of 786015 shares changing hands. Canaccord Genuity Group raised their price target on ...
MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock Rating Reaffirmed by Needham & Company LLC
ETF DAILY NEWS· 4 hours agoMoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report)‘s stock had its “buy” rating reiterated by Needham & Company LLC in a research report issued to clients and investors on Monday, Benzinga ...